Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients
Patients with advanced Parkinson's disease (PD) experience body weight loss and reductions in the most common cardiovascular risk factors. At present, the pathogenetic mechanisms involved have not been elucidated. Increased serum concentrations of adiponectin, which possesses antiatherogenic an...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
SAGE-Hindawi Access to Research
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135047/ |